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To improve the detection of phosphorylated peptides/proteins, a combination of optimized
MS-based strategies were used involving chemical derivatization with a polyhistidine-tag
(His-tag) and affinity enrichment of the resulting His-tag peptides on a nanoscale Ni2-IMAC
column. The phosphoserine and phosphothreonine peptides were derivatized using a
one-pot -elimination/Michael addition reaction with a reversible His-tag possessing a
thiol-containing Cys residue. The His-tag peptides were enriched selectively by Ni2-IMAC
and released using either imidazole or cleavage with Factor Xa. This novel capture and
enzyme-mediated release provided an additional element of selectivity and yielded
phosphopeptide-specific modifications with enhanced MS ionization characteristics. The
eluted peptides were mapped using MALDI-TOF MS and QTRAP ESI-MS/MS techniques.
The results obtained for a model peptide and two tryptic protein digests show that the method
is highly specific and allows selective enrichment of phosphorylated peptides at low
concentrations of femtomoles per microliter. (J Am Soc Mass Spectrom 2007, 18, 1007–1017)
© 2007 American Society for Mass SpectrometryOne of the best-known mechanisms for covalentmodification, occurring in as many as one thirdof eukaryotic gene products, is protein phos-
phorylation, which regulates fundamental cellular
events: cell division, cell growth, and cell differentia-
tion. Because protein phosphorylation and other post-
translational modification cannot be predicted using
gene sequence, several strategies have been used. The
conventional approach for the detection of phosphory-
lation sites typically involves radioactive labeling of the
phosphorylation site in growth media, followed by the
isolation of 32P-labeled phosphorylated protein by im-
munoprecipitation or SDS-PAGE, enzymatic digestion,
and Edman degradation [1, 2]. This approach, besides
being a potential hazard, suffers from reduced sensitiv-
ity arising from the low abundance of phosphoprotein,
limited amount of biological sample, inefficient incor-
poration of the 32P label, and relatively poor sensitivity
of automated Edman sequencing.
Mass spectrometry, which has long been used to
identify proteins, is now the preferred technique for
mapping post-translational modifications in proteins
[3– 6]. The analysis is rapid, sensitive, and does not
require radiolabeling. Two soft ionization techniques—
matrix-assisted laser desorption/ionization mass spec-
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doi:10.1016/j.jasms.2007.02.010trometry (MALDI-MS) and electrospray ionization
mass spectrometry (ESI-MS)—have been successful in
detecting the phosphorylation sites in proteins [7, 8].
However, in routine phosphopeptide mapping using
MS, the following challenges appear. First, negative
charges on phosphate groups result in suppression
effects or a low efficiency of ionization. Second, the low
stoichiometry and abundance of phosphorylated pep-
tides in a mixture of peptides makes the exclusive
characterization of phosphopeptides difficult. Third,
the hydrophilic character of phosphopeptides may
cause them to elute in the void volume in RP-HPLC.
Finally, full sequence coverage by specific proteolysis of
large phosphoproteins is difficult. These factors under-
score the need for continued development of methods
of enrichment before mass analysis [5, 8].
A common technique for enrichment of phosphor-
ylated peptides and proteins from a complex mixture
is immobilized metal ion affinity chromatography
(IMAC) [9]. Phosphoproteins and peptides bind with
specificity to immobilized metal ions, such as Fe3,
Al3, and Ga3 and usually elute at high pH values.
However, the elution of phosphopeptides from IMAC
resins can result in the loss of strongly bound phos-
phopeptides. Also, non-specific binding of negatively
charged species may occur during the IMAC procedure
[8 –10]. In this case, a methylation step is essential to
partially reduce the non-specific binding of highly
negatively charged peptides to the resins [11]. Alkaline
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which causes the loss of a phosphate group and shifts
the mass by 80 Da, can further confirm the existence
of phosphorylation sites and also enhances ionization
efficiency [12]. The use of strong cation exchange chro-
matography before IMAC purification to further reduce
the complexity of the sample and to yield a better
coverage of monophosphorylated peptides has also
been reported [13, 14]. Recent studies have shown that
nanocomposites such as titanium dioxide (TiO2) and
zirconium dioxide (ZrO2) have a high loading capacity
and specificity for phosphopeptides in large-scale anal-
yses of protein phosphorylation in biological mixtures
[15, 16]. Two MS-based strategies—precursor ion scan-
ning of m/z 79 in negative-ion mode and neutral loss
scanning of m/z 98 in positive mode—have been used
for selective detection of phosphorylated peptides
within a complex mixture [17, 18].
Chemical derivatization strategies based on -
elimination of the phosphate moiety of phosphopep-
tides and Michael addition reaction with S- and
N-nucleophiles, such as ethanethiol, ethanedithiol,
and ethylenediamine, are increasingly being de-
scribed [19, 20]. In a recent study, Knight et al. [21]
applied a phosphorylation-specific proteolysis tech-
nique, which converts the phosphorylation sites into
lysine analogs using a -elimination/Michael addition
reaction. The resulting modified peptide can then be
cleaved phosphospecifically by LysC endoprotease.
Other chemical derivatization approaches have been
developed based on the incorporation of biotin or
fluorous affinity tags to aid the enrichment of phos-
phopeptides [22–24]. Although each of these methods
has its own advantages and certain limitations, the
development of new approaches for unambiguous,
specific, and selective analysis of phosphoproteins to
reduce suppression effects and enhance the detectabil-
ity of phosphopeptides is still ongoing.
In the present work, a -elimination/Michael addi-
tion reaction is used to replace the phosphate moiety of
phosphoserine and phosphothreonine peptides with a
His-tag. The thiol group on the side chain of Cys of the
His-tag reacts with the dehydroalanine residue interme-
diate that is formed by the loss of phosphate moiety in
alkaline conditions. His-tag peptides are enriched selec-
tively by Ni2-IMAC and mapped using MS and
MS/MS techniques. Removal of the reversible His-tag
ligand is achieved using Factor Xa, which cleaves the
His-tag peptide at the C-terminal side of Arg of the
recognition sequence, thus liberating the immobilized
peptide. Our novel enrichment strategy, in addition to
the affinity purification of phosphopeptides from a
complex mixture, improves the selectivity and specific-
ity of analysis as a result of the specific recognition site
of protease Factor Xa that is engineered into the His-tag
linker. It is well known that the detailed analysis of
MS/MS spectra of phosphopeptides with multiple
phosphorylation sites using ion trap instruments re-
mains challenging because of neutral loss of 98 Da fromeach site. In our study, the final peptide used for MS
analysis incorporates a Gly-Cys dipeptide linked
through the thiol side chain of Cys at the site of
phosphorylation. This modification significantly im-
proves ionization efficiency because of the substitution
of the negatively charged phosphate group, aids pep-
tide fragmentation and thus facilitates identification of
the precise sites of phosphorylation.
Experimental
Amino acids and solvents were purchased from Nova-
biochem (San Diego, CA, USA) or Fisher Scientific (Fair
lawn, NJ, USA). -Casein (bovine) was purchased from
Sigma–Aldrich/New Jersey Center for Biomaterials
(Piscataway, NJ, USA). Inhibitor-1 (I-1) was provided
by Dr. James Bibb (UT Southwestern Medical Center at
Dallas, TX, USA). The materials used were barium
hydroxide (Alfa Aesar, Ward Hill, MA, USA), gallium
nitrate [Ga(NO3)3], guanidinium HCl, formic acid, tri-
fluoroacetic acid (TFA), hydrogen peroxide (Sigma–
Aldrich), Poros 20MC (PE Biosystems, Framingham, MA,
USA), Factor Xa (Qiagen, Valencia, CA, USA), titanium
oxide (ESPI, Ashland, OR, USA), and sequencing-grade
modified trypsin, porcine (Promega, Madison, WI, USA).
All matrices, -cyano-4-hydroxycinnamic acid (CHCA),
2,5-dihydroxybenzoic acid (DHB), and sinapinic acidwere
purchased from Agilent Technologies (Palo Alto, CA,
USA).
Synthesis of His-tag and Model Phosphopeptide
The His-tag peptide (m/z 1512.69, HHHHHHGIEGRGC)
and model phosphopeptide [m/z 1732.75, RPHFPQFS
(PO4)YSASGTA], representing the C-terminal tryptic frag-
ment of RAC- serine/threonine-protein kinase (P47196)
were synthesized on an automated ABI 433 peptide syn-
thesizer (Applied Biosystems, Foster City, CA, USA) using
optimized Fmoc/tBu chemistry on Fmoc-amide resin [26].
Crude peptides were purified by RP-HPLC (Waters, Mil-
ford, MA, USA) and then analyzed with MALDI-MS to
confirm their identity. The purified fractions were pooled
together and then lyophilized.
His-tag Derivatization
For the model phosphopeptide; the -elimination/
Michael addition reaction was performed using 10 L
of phosphopeptide (10 pmol), 10 L nucleophile
(1 nmol), 5 L of 8 M guanidine HCl, 5 L of ACN, and
10 L of saturated barium hydroxide. Addition of these
derivatizing chemical reagents further diluted the 10
pmol of phosphopeptide to a final concentration of
250 fmol/L. The reaction was allowed to proceed for
3 h at 45 °C. For -casein and I-1 protein samples, before
derivatization, the protein mixture was subjected to
performic acid oxidation by adding 50 L of 30%
aqueous hydrogen peroxide: 95% formic acid (5:95
vol/vol) to 20 g of protein. The reaction mixture was
addit
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vacuum system. The dried sample was dissolved in
100 L of 100 mM ammonium bicarbonate. Trypsin
digestion of oxidized proteins was performed at 37 °C
overnight using the substrate/enzyme ratio of 100:1.
The resulting mixture was diluted to 1 pmol/L using
0.1% formic acid. The resulting solution (10 L) was
used for derivatization. The derivatization of the result-
ing tryptic phosphorylated peptides followed the same
procedure as described above, giving a final concentra-
tion of 250 fmol/L.
Ga3-IMAC Enrichment
The method was performed according to the Millipore
(Bedford, MA, USA) instructions for ZipTip® (www.
millipore.com). Briefly, the tip was equilibrated by
washing with 10 L of freshly prepared 0.1% acetic acid
in 50% ACN and primed using 10 L Ga(NO3)3 in 10
mMHCl. Then the column was washed first with 10 L
of Milli-Q water, followed by 10 L of 1% acetic acid
containing 10% ACN. The samples were diluted with 10
L of 0.1% acetic acid, applied to the top of the column,
washed with 0.1% acetic acid, followed by 0.1% acetic
acid in 10% ACN, and finally rinsed with Milli-Q water.
The phosphopeptides were eluted from the column
with 10 L of 0.3 M ammonium hydroxide solution and
the eluent acidified before C18 ZipTip desalting and
MALDI-MS analysis.
TiO2 Enrichment
TiO2 powder was resuspended in 80% ACN in 0.1%
TFA and then packed into an Eppendorf gel-loader tip,
which was blocked with a glass-wool frit. To optimize
Scheme 1. -Elimination and Michaelthe binding of protein to the TiO2 micro-column, the pHvalues of the digested proteins were adjusted to 6.5. The
resulting mixture was introduced into the TiO2 micro-
column and washed with 0.1% acetic acid followed by
50% ACN in 0.1% acetic acid. The bound phosphopep-
tides were eluted with 0.5% ammonium hydroxide
(pH 9.5).
His-tag/Ni2-IMAC Enrichment
The His-tag peptides were enriched using nanoscale
Ni2-IMAC. First, the Poros 20MC was prepared by
suspending the resin in 20 mM NiCl2 in 10 mM HCl. A
nanoliter IMAC column was prepared by loading the
IMAC resin into an Eppendorf gel-loader tip. The resin
was washed with deionized water and the binding
buffer (20 mM Tris HCl, 5 mM imidazole, 0.5 M NaCl,
pH 8). A 5L sample was diluted further with 5 L
binding buffer and loaded on the top of the column. The
bound His-tagged peptides were washed with a buffer
containing 60 mM Tris HCl, 5 mM imidazole, 0.5 M
NaCl (pH 8), and either eluted with solution containing
20 mM Tris HCl, 0.5 M imidazole, 0.5 M NaCl (pH 8) or
treated with 10 L Factor Xa to liberate the immobilized
peptide. (Note: His-tag/Factor Xa recognition site,
HHHHHHGIEGR, remains attached to the IMAC.) The
samples were desalted using Millipore C18 ZipTip
(Millipore), washed with 10 L of 1% formic acid, and
finally eluted with 50% ACN containing 1% formic acid.
The eluent was analyzed on MALDI-MS and QTRAP
ESI-MS/MS.
Mass Spectrometry Analysis
Mass spectrometry analyses were performed using a
time-of-flight MALDI-MS (Micromass LR MALDI-TOF,
ion reaction of phosphorylated peptide.Manchester, UK) and a 4000 QTRAP triple quadrupole/
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following settings were used for the QTRAP experi-
ments: nano-ionspray voltage 2000 V, no heating of
the source, curtain gas 20 psi, and declustering potential
110 V. Identification of phosphorylation sites and
fragmentation was achieved by using MS product of
Protein Prospector database. For MALDI-MS analysis, a
0.5L aliquot of the sample was deposited onto the
MALDI plate and then 0.5 L of the working matrix
(DHB and sinapinic acid) solution was applied to the
sample droplet. DHB was used for the lower mass scale
500 to 2000 Da and sinapinic acid was used for identi-
fication of His-tag and phosphopeptides for mass
range above 2000 Da. The sample-matrix droplet was
allowed to air-dry at room temperature. Typically,
spectra were obtained using a pulsed nitrogen UV
laser (337 nm; 3 ns) in positive linear and reflectron
mode; pulse voltage of 2800 mV; source voltage of
15,000 mV, using the MassLynx 4.0 Software (Waters
Laboratory Informatics).
Results and Discussion
Analytical Strategy
Chemical modification—based on the alkali-mediated
-elimination of phosphoric acid from phosphoserine
and phosphothreonine residues followed by Michael
addition—was used for the enrichment and identifica-
tion of phosphorylation sites. Several bases including
barium hydroxide, sodium hydroxide, and ammonium
bicarbonate based on previous studies were used for
the -elimination reaction. Although all of these bases
generated -elimination products, the results confirmed
that barium hydroxide in ACN gave a higher yield for
the attachment of the His-tag derivative to the double
bond of the dehydroalanine intermediate. Many reports
show that the thiol group is an efficient and fast-
reacting nucleophile for Michael addition reactions
[19 –22]. Therefore, we designed a His-tag sequence
consisting of three functional domains separated by Gly
spacers. These were six histidines for binding to Ni2-
IMAC, a Factor Xa recognition site (Ile-Glu-Gly-Arg),
and a sulfhydryl-containing Cys residue at the C-
terminus of the peptide to act as nucleophile for attach-
ment at the site of phosphorylation (Scheme 1).
Typically, the His-tag is introduced on the N- or
C-termini and used as a means to affinity purify recom-
binant proteins from a bacterial expression system. In
our research, we have adopted this approach for enrich-
ment of phosphopeptides using Ni2-IMAC, which
binds the His-tag with micromolar affinity. The bound
His-tag peptides were washed and eluted with 0.5 M
imidazole. Alternatively, the presence of the Factor Xa
recognition site in the His-tag enables the bound
peptides to be specifically detached from the column
using Factor Xa protease. This protease recognizes
the Ile-Glu-Gly-Arg sequence, cleaving the His-tag
peptide and liberating the modified sequence peptidewith the Gly-Cys dipeptide attached at the site of
phosphorylation. The His-tag/Factor Xa recognition
site sequence remains attached to the IMAC resin
(Scheme 2).
The specificity of Factor Xa adds a further dimension
of selectivity to the analysis by leaving non-specific
binders attached to the column. Furthermore, enrich-
ment techniques that rely on binding of phosphopep-
tides to Ga3 or Fe3-IMAC often suffer from incom-
plete elution from the column using high pH buffers.
Recently, a mixture of DHB and phosphoric acid has
been shown to be an efficient eluent for Fe3-IMAC and
TiO2 columns [27, 29]. Although this mixture is suitable
for MALDI-MS analysis, it is not compatible with
ESI-MS, commonly used for phosphopeptide analysis.
Factor Xa treatment is potentially a more reliable ap-
proach that may ultimately result in better recovery and
thus sensitivity. The strategy was tested using the
Scheme 2. His-tag enrichment strategy for the selective analysis
of phosphopeptides.model peptide as well as phosphoprotein -casein.
eptid
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phosphorylation status of I-1 (a substrate for cyclin-
dependent kinase 5 and potent inhibitor of protein
phosphatase 1). The experiments were performed at
least three times to optimize the methodology and test
the reproducibility. Qualitatively, the same modified
peptides were recovered with each experiment under
identical conditions and with similar yield.
Phosphopeptide Enrichment of a Model Peptide
To optimize the reaction conditions for derivatization, a
model phosphopeptide (Figure 1a; m/z 1732.79) and
reversible His-tag, as nucleophile, were used. The
MALDI-MS spectrum of the modified peptide shows
the peak of m/z 1635.92 (Figure 1b) for the dihydroala-
nine intermediate, resulting from the loss of phosphate.
The peak at m/z 3147.43 (Figure 1c) corresponds to the
His-tag modified peptide. The His-tag peptide was
enriched on the Ni2-IMAC column and bound pep-
tides were eluted with 0.5 M imidazole. The eluent from
IMAC was acidified with 5% acetic acid, desalted on a
C18 ZipTip, and analyzed by MALDI and QTRAP-MS.
All MALDI-MS data were obtained using linear ion
mode because it improved and enhanced the signal
generated by the phosphopeptides and His-tag derivat-
ized peptides. Holland et al. [28] reported that peaks
Figure 1. MALDI-MS spectra of (a) a model
derivatization with His-tag (0.5 M imidazole
purification (after Factor Xa treatment). MALDI
after (f) Ga3-IMAC purification, (g) enrichment
purification after Factor Xa treatment. Phosphopcorresponding to post-translational modified peptidessuch as phosphorylation and glycosylation, which do
not appear in the reflectron mode MALDI analysis, may
appear in the linear mode. The peak of m/z 3147.43
(calculated m/z 3147.46) was clear in the spectrum after
enrichment. Treatment of His-tag peptides with Factor
Xa, which leaves a Gly-Cys dipeptide at the site of
phosphorylation, resulted in a shift in molecular weight
to a lower mass of m/z 1812.39 (calculated m/z 1812.04)
(Figure 1d). Non-specific binders such as m/z 1668.95
remained attached to the IMAC column because these
did not possess the Factor Xa recognition site and, as a
result, are absent in the MS spectrum (Figure 1d).
The data obtained show highly selective enrichment
before MS analysis because of the combination of
nanoscale IMAC, Factor Xa treatment, and the exclusive
elimination of interference from other highly acidic
peptides. However, MS/MS sequencing is required to
unambiguously determine the phosphorylation sites.
Figure 2a shows the MS spectrum of 3 and 4
charged ions of His-tag peptide at m/z 1050.31 and
788.16, respectively. The peak of the His-tag ligand and
its dimer are also present in this spectrum. After puri-
fication and treatment with Factor Xa, the His-tag–
modified peptide is cleaved at the carboxyl side of Arg,
leaving Gly-Cys attached to the tryptic peptide. Conse-
quently, the mass of the doubly charged ion shifts to
m/z 906.96 (Figure 2b). The model peptide contains a
sphopeptide, (b) after -elimination, (c) after
tment), and (d) His-tag peptide after IMAC
pectra of -casein (e) before derivatization and
TiO2, and (h) His-tag derivatization and IMAC
es and modified peptides marked with *.pho
trea
-MS s
usingphosphate group on Ser8 and the MS/MS data clearly
spec
nd Fa
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residues present in the sequence after its modification
with Gly-Cys (Figure 2c).
Phosphopeptide Enrichment of -Casein
To further evaluate this methodology we decided to use
the His-tag for the chemical derivatization of -casein, a
milk-derived protein, which possesses multiple phos-
phorylation sites. A previous study using mass spec-
trometry shows the presence of two variants with low
sequence homology in the commercially available -
casein. Carr et al. [17] detected nine phosphorylation
sites using precursor ion scanning on an ESI/MS instru-
ment. However, they were not able to sequence all the
phosphopeptides, especially those phosphopeptides
with multiple phosphorylation sites attributed to the
ionization suppression effects described previously
Figure 2. ESI-MS spectrum of (a) His-tag pep
[M3H]3 ion. (b) ESI-MS and (c) ESI-MS/MS
[M2H]2 ion), after Ni2-IMAC purification a[17]. Larsen et al. [29] detected ten phosphorylatedpeptides from -casein after TiO2 enrichment using
MALDI-MS, including monophosphorylated and mul-
tiphosphorylated peptides. When samples were ana-
lyzed with ESI-MS, there was a bias towards the
monophosphorylated species and several multiphos-
phorylated species, previously detected by MALDI-MS,
were not observed. They attribute this finding to a
lower amount of multiphosphorylated peptides com-
pared to monophosphorylated peptides.
Phosphopeptides have traditionally been enriched
using Fe3- and Ga3-IMAC and, more recently, TiO2
bound to immobilized supports. To compare the selec-
tivity and sensitivity of the His-tag strategy with these
well-established methods, the same solution of -casein
was enriched with either Ga3-IMAC, TiO2, or His-tag.
The imidodiacetic acid (IDA) and nitrotriacetic acid
(NTA) resins commonly were used as stationary phase
for metal ions in IMAC columns. Although NTA resin
before IMAC purification m/z 1050.33 for the
tra of Gly-Cys derivatized peptide (m/z 906.96;
ctor Xa treatment.tidewas superior to IDA resin, non-phosphorylated pep-
H]2 
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dues, are frequently enriched by this method. In our
experiment, both IMAC ZipTip with the IDA resin and
NTA-Poros 20MC resins were used for the enrichment
of phosphopeptides and His-tag peptides. Almost the
Figure 3. (a) ESI-MS and (b) ESI-MS/MS spec
-S1 [119 –134] after modification, IMAC pu
[M2H]2 ion). (c) ESI-MS/MS spectrum of the
before His-tag derivatization (m/z 977.07; [M2same result was obtained with both resins. Three phos-phopeptides were identified using Ga3-IMAC (Figure
1f), eight phosphopeptides from TiO2 enrichment (Fig-
ure 1g), and four phosphopeptides were readily de-
tected using His-tag enrichment/Factor Xa treatment
(Figure 1h). The eight phosphopeptides identified using
f Gly-Cys derivatized -casein phosphopeptide
tion, and Factor Xa treatment (m/z 1016.54;
ursor phosphopeptide YKVPQLEIVPNS*AEER
ion).tra o
rifica
 precTiO2 were -S2(141–151) at m/z 1331.53 (one phosphate
1014 JALILI ET AL. J Am Soc Mass Spectrom 2007, 18, 1007–1017group) and 1411.71 (two phosphate groups), -S2(153–
165) at m/z 1594.65 (one phosphate group), -S2(141–
152) at m/z 1539.60 (two phosphate groups), -S1(121–
134) at m/z 1660.80 (one phosphate group), -S1(58–73)
at m/z 1863.27 (one phosphate group, oxidized form),
-S1(119–134) at m/z 1951.95 (one phosphate group),
and -S1(74–94) at m/z 2736.73 (five phosphate groups,
oxidized form).
In the present work, before chemical derivatization,
the proteins were first subjected to performic acid
treatment, which oxidizes cysteine, methionine, and
tryptophan residues. This pretreatment blocks any un-
desirable side reactions that may occur between the Cys
residue on the His-tag and Cys residues present in the
-casein sequence. The peak of phosphorylated tryptic
-casein peptide at m/z 1951.91 (calculated m/z 1951.95)
gains intensity at m/z 3366.66 (calculated m/z 3366.67)
after His-tag derivatization and IMAC purification
(data not shown). The peak of the corresponding puri-
fied derivatized peptide after Factor Xa treatment (Fig-
ure 1h) appears at 2031.61 (calculated m/z 2031.22).
Figure 4. The MALDI-MS spectra of I-1 (a) bef
(c) TiO2 purification, and (d) after His-tag de
treatment.Similarly, other phosphopeptides with masses m/z1411.71 (two phosphate groups), 1539.60 (two phos-
phate groups), and 1660.79 (one phosphate group) shift
to m/z 1570.85, 1697.51, and 1740.06, respectively, as a
result of the substitution of the phosphate group with
the Gly-Cys dipeptide (Figure 1h). The replacement of
two phosphate groups on serine residues with the
Gly-Cys dipeptides in EQLS(GC)TS(GC)EENSK tryptic
peptide demonstrates that the method works effectively
for multiple phosphorylation sites, including those in
close proximity. The MALDI-MS spectrum after enrich-
ment was significantly less complex than that obtained
for the tryptic digest of -casein. Treatment of enriched
immobilized His-tag peptides with Factor Xa pro-
vided further selectivity and specificity of the method
and improved ionization efficiency arising from the
substitution of phosphate group with Gly-Cys. It also
removed the non-specific binders including the mono-
meric and dimeric forms of the His-tag ligand that
might otherwise interfere with the MS analysis. Com-
pared with the result obtained with TiO2 column where
eight phosphopeptides were observed, the His-tag
erivatization, (b) after Ga3-IMAC purification,
zation and IMAC purification after Factor Xaore d
rivatishows four phosphorylated peptides (two monophos-
SPEV
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reason could be the low abundance and stoichiometry
of the multiphosphorylated species. Data presented by
Larsen et al. [29] support this finding as they observed
a significantly lower sensitivity for multi-phosphory-
lated peptides using ESI-MS/MS.
The MS (Figure 3a) and MS/MS (Figure 3b) spectra
of the derivatized peptide were obtained using a
QTRAP 4000. Although the y and b ions dominate
the spectrum, the series of y ions are more complete
and better coverage was observed over the high
m/z region. The fragment obtained corresponds to
YKVPQLEIVPNSAEER and the mass of 160.04 Da
was added to all fragments from y5 to y 15, which is
attributed to the addition of Gly-Cys dipeptide at the
site of phosphorylation (Ser12).
To demonstrate that the ionization characteristics of
the peptide improved, another MS/MS experiment was
performed on the unmodified phosphorylated precur-
sor peptide, using the same collision energy settings
(Figure 3c). In the MS/MS spectrum of the correspond-
ing phosphopeptide, the most abundant and intense
peak was that of the doubly charged ion highlighting
the difficulty of ionizing and fragmenting these phos-
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Figure 5. (a) ESI-MS and (b) ESI-MS/MS spec
858.16; [M3H]3 ion) after modification, Ni2
corresponding sequence is RPT*PATLVLTSDQSphorylated species. In comparison, the series of b and yions are far more intense in the case of the peptide
modified with Gly-Cys. In agreement with the results,
substitution of a negatively charged phosphate for a
protonated group may improve ionization efficiency of
the species of interest, augment CID backbone fragmen-
tation, and, as result, facilitate phosphorylation site
identification.
Phosphopeptide Enrichment of I-1
Inhibitory subunit 1 (I-1) is derived from precursor
protein phosphatase (PP1), which is a major eukaryotic
Ser/Thr phosphatase. PP1 regulates diverse cellular
processes such as glycogen metabolism, cell division,
muscle contraction, signal transduction, and neuronal
functions. PP1 has targeting and inhibitory subunits.
The targeting subunits confer substrate specificity and
inhibitory subunits suppress the catalytic activity of
PP1. I-1 is phosphorylated on Thr35 and Ser67 in vivo.
Once phosphorylated on Thr35, I-1 becomes a potent
inhibitor of PP1 [30]. The MALDI-MS spectrum of
tryptic digest of I-1 before enrichment shows the peak
of the phosphopeptide at m/z 2494.58 has very low
intensity arising from either the low stoichiometry or
ray) Max. 8.8e5 cps.
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1016 JALILI ET AL. J Am Soc Mass Spectrom 2007, 18, 1007–1017In our study, the phosphorylation site on Thr35 of I-1
was investigated using His-tag affinity enrichment and
compared to Ga3-IMAC and TiO2. Although, the latter
techniques are definitely effective for the signal en-
hancement of low amounts of phosphopeptides from a
complex mixture of tryptic peptides, the expected selec-
tivity was not observed. The peaks of acidic peptides
were also seen in the spectra but with lower intensity
compared to the spectrum before enrichment. For in-
stance, the peaks at m/z 1678.92 (ELQTMVEHHLGQQK)
and 2030.07, which are the most abundant peaks in the
spectrum of I-1, are also evident after enrichment using
Ga3-IMAC and TiO2 (Figure 4b and c). However, these
non-specific sequences are absent in spectra after His-
tag enrichment and the peak of Gly-Cys–modified
peptide appears with high intensity at m/z 2573.31
(calculated mass 2573.82) (Figure 4d). The spectrum
after enrichment and elution with Factor Xa is clear
from other tryptic peptides and even highly acidic
peptides, demonstrating the increased selectivity of the
method.
Sequencing the triply charged ion of the Gly-Cys–
derivatized peptide at m/z 858.52 (Figure 5b) using
ESI-MS/MS suggested that the sequence corresponded
to RPT*PATLVLTSDQSSPEVDEDR, with Gly-Cys
dipeptide providing a convenient marker for identify-
ing the site of phosphorylation.
Conclusion
The combination of chemical derivatization with His-
tag and affinity enrichment using Ni2-IMAC is a
highly efficient approach for identification of low-level
concentrations of phosphorylated peptides in a com-
plex mixture of peptides. Although the number of
identified phosphopeptides is higher using TiO2, the
data presented here show that the treatment of enriched
derivatized peptides with Factor Xa improves selectiv-
ity by eliminating a greater proportion of contaminating
non-specific negatively charged species. Furthermore,
substituting a phosphate group with a protonatable
Gly-Cys dipeptide offers definite advantages over the
phosphorylated precursor when analyzed by ESI-
MS/MS in positive mode. In addition, phosphatases,
high pH conditions, and ionization in the ion trap MS
instruments can cause loss of phosphate groups,
resulting in lower sensitivity and increased difficulty
identifying the phosphorylation sites. In this respect
modification with the Gly-Cys dipeptide facilitates
phosphorylation site identification. Results of this
research confirm that this innovative method pro-
vides a reliable means of phosphopeptide mapping
that offers advantages over published enrichment
methods.
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